Delivery Order SPE2DB20D3111-SPE2DB26FA5QF
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) valued at $1,988.27. This firm fixed-price delivery order is due for completion by November 6, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition without set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) with a ceiling value of $42,178.80. This firm fixed-price delivery order, which is set to be completed by July 22, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical will be delivered to the company's corporate office location in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on April 24, 2025, by the Defense Logistics Agency to supply Eliquis 5 mg tablets (60-count packages) with a ceiling value of $38,436.76. This firm fixed-price delivery order, which has an ultimate completion date of April 25, 2025, represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Eliquis 5 mg tablets (60-count) with a ceiling value of $5,416.97. This firm fixed-price delivery order, with an ultimate completion date of September 25, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Eliquis 5 mg tablets (60 count) valued at $12,428.16. This firm fixed-price contract, which is not set-aside, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order is scheduled for completion by November 3, 2025,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 1, 2025, for the supply of Eliquis 5 mg tablets (60-count packaging) valued at $2,635.82. This competitively awarded, firm fixed-price delivery order is scheduled for completion by May 2, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets in a 60-count package under a firm fixed-price contract with a ceiling value of $30,643.41. This non-competitive delivery order, issued on November 3, 2025, represents a child contract against AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The order will be fulfilled from the company's facility in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Eliquis 5 mg tablets (60-count units) with a ceiling value of $49,357.52. This firm fixed-price delivery order, which is expected to be completed by June 4, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60 units. This is a firm fixed-price delivery order valued at $6,579.27, with performance scheduled for completion by November 5, 2025, at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award was made on a competitive basis without any set-aside designation. This delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $5,199.39 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count) on October 28, 2025, with completion scheduled for October 29, 2025. This non-competitive, firm fixed-price delivery order represents a continuation of pharmaceutical supply under the company's existing contract vehicle with the federal government. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- SPE2DB20D3111Indefinite Delivery Contract
- SPE2DB20D3111-SPE2DB26FA5QFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Eliquis 5 mg tablets (60-count) with a ceiling value of $1,060.28. This firm fixed-price delivery order, which must be completed by November 5, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was not set aside and was competitively awarded, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement requirements. The performance location is the vendor's corporate headquarters in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, serves military and veteran healthcare systems through its extensive portfolio of brand-name and generic medications. The company holds a comprehensive IDC valued at $999,999,999.00 with DLA Troop Support Medical (designated SPE2DX) through December 2026, which serves as the vehicle enabling supply of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order for Eliquis, an anticoagulant medication, exemplifies the company's role in fulfilling specialized pharmaceutical needs for the Department of Defense healthcare enterprise through flexible contract mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 11/4/25 |